EN DE ES FR IT Primary Menu NEWS April 16, 2020 Primex Pharmaceuticals with the support of TheSi Farma, launch OZASED® … Read More ... NEWS February 25, 2020 OZALIN® continues to receive marketing authorization approvals across EU Read More ... Primex Pharmaceuticals: The leading global ‘commercially focused’ innovative Anaesthesia company Triad Of Anaesthesia Primex brings a portfolio of anaesthesia products helping patients undergo a wide range of medical procedures, including a novel, oral solution for paediatric sedation now approved in several markets in the European Union. Primex Pharmaceuticals will continue to identify and bring to the market new medications that complete the Triad of Anaesthesia. About Us Primex Pharmaceuticals is a fast-growing global specialty pharma company spearheading a new lean pharmaceutical business model. The company is headquartered in Zug, Switzerland; all Primex products are manufactured in Europe. Primex Pharmaceuticals has proven underlying business operations and historically strong revenue growth. TOP © 2018 Primex Pharmaceuticals. All Rights Reserved. Privacy Policy | Conditions of Use | Drug Safety Reporting Privacy Policy

EN DE ES FR IT Primary Menu News April 16, 2020 Primex Pharmaceuticals with the support of TheSi Farma, launch OZASED® in Italy Zug, 16th April 2020, Swiss company Primex Pharmaceuticals is working with the contract sales company TheSi Farma to launch OZASED to the Paediatric Anaesthesia community in Italy. OZASED® (oral midazolam) is indicated for children from 6 months to 17 years for moderate sedation before therapeutic or diagnostic procedures, and as premedication prior to anaesthesia. OZASED® comes ready to use and requires no preparation unlike the current practice of manipulating intravenous midazolam for oral administration in paediatric patients given the lack of alternative licensed oral solutions in the indication. Alan Knox, CEO of Primex, comments: “Our collaboration with TheSi Farma allows Primex to enter the Italian market directly by managing the whole marketing and sales process through the promotion of OZASED® to the Paediatric Anaesthesia medical community. TheSi Farma also support Primex in the management of the process of distribution through an Italian wholesaler and into the Hospital pharmacies ensuring we are on the IHS national hospital platform. TheSi are a well-established company in the Italian market with significant expertise.” For further information, please contact: www.primexpharma.com For further information, please contact: www.thesifarma.it OZASED® is called OZALIN® in some countries © Primex Pharmaceuticals AG, Zug, Switzerland. All rights reserved LOAD MORE NEWS TOP © 2018 Primex Pharmaceuticals. All Rights Reserved. Privacy Policy | Conditions of Use | Drug Safety Reporting Privacy Policy